Profile picture

Doctor Elisa Avolio

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.
Presentation
Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling
Presentation
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling
Rescue of cardiac function in obese type-2 diabetic mice by transfer of a human longevity gene
Presentation
Rescue of cardiac function in obese type-2 diabetic mice by transfer of a human longevity gene
A short term treatment with a Mek1/2 inhibitor promotes myocardial arteriogenesis and perfusion in vivo: focus on cardiac mural cells
Presentation
A short term treatment with a Mek1/2 inhibitor promotes myocardial arteriogenesis and perfusion in vivo: focus on cardiac mural cells
Human adventitial pericytes secrete bioactive factors exerting distinct biological effects on cardiac cells: hints for cardiac repair
Presentation
Human adventitial pericytes secrete bioactive factors exerting distinct biological effects on cardiac cells: hints for cardiac repair
Selective inhibition of the Mek1/2-Erk1/2 signalling pathway induces the differentiation of human cardiac pericyte-like cells into contractile vascular smooth muscle cells
Presentation
Selective inhibition of the Mek1/2-Erk1/2 signalling pathway induces the differentiation of human cardiac pericyte-like cells into contractile vascular smooth muscle cells
Generation of tissue engineered vascular grafts with neonatal cardiac pericytes for application in congenital heart disease
Presentation
Generation of tissue engineered vascular grafts with neonatal cardiac pericytes for application in congenital heart disease

ESC 365 is supported by